Better than another keyword alert
Keyword alerts are noisy because they match language, not importance. ElixirFeed is designed to ask whether a paper deserves attention after evidence and impact screening.
Biotech research feed
Biotech research feed for founders, operators, and science teams
ElixirFeed filters biomedical research for high-impact papers that can help biotech builders spot clinical, translational, and scientific signals.
Scan
Score
Explain
biotech research feed
Selection is the product.
Biotech teams need a quick way to notice meaningful biomedical papers without drowning in keyword alerts. ElixirFeed screens broad PubMed output and brings selected research into a compact feed.
Highlights translational and clinically relevant studies
Uses author, institution, and journal context without over-weighting prestige
Turns selected papers into fast briefs for monitoring and discussion
Workflow
From research firehose to short ranked feed
ElixirFeed keeps the ranking workflow visible because the differentiator is the filter, not generic article rewriting.
Scan broad PubMed output
ElixirFeed starts with the biomedical firehose rather than one narrow keyword query.
Discard low-signal candidates
Records without usable abstracts and obvious low-impact matches are removed before enrichment.
Rank by evidence and impact
Human evidence, clinical relevance, public usefulness, novelty, journal context, and prominence signals shape the score.
Explain only selected papers
The highest-ranking studies become readable briefs with takeaways, caveats, categories, and source links.
Useful outside your exact domain
The broad biomedical taxonomy helps surface signals across diseases, human health, public health, fundamental science, and medical innovation.
Fast enough for weekly review
The ranked feed and weekly digest are built for scanning, saving, and discussing the studies most likely to be worth follow-up.
Built for high-signal readers
Biotech founders tracking adjacent science
Operators monitoring therapeutic and diagnostic shifts
Investors and analysts building research awareness
Questions readers ask
ElixirFeed is a research discovery product, not medical advice or a replacement for source-paper review.
What makes this useful for biotech teams?
It reduces PubMed alert noise and emphasizes evidence strength, translational relevance, novelty, and credible research context.
Can ElixirFeed replace domain experts?
No. It is a discovery and triage tool. Expert review is still necessary before any strategic, clinical, or investment decision.
Does the feed include medical innovation?
Yes. Medical innovation is one of the broad categories used in the post-pivot taxonomy.
Read the feed that already did the filtering
Start with the public preview, then create a free account when you want the regular recent feed.